GlassScriptPhysician profile
Sean P Caufield
NPI 1669536439
$6,303.57
in general payments reported to CMS, 2019-2025
36 companies · $1,323 in 2025
The $1,323 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,089 · 2020: $337 · 2021: $268 · 2022: $734 · 2023: $1,254 · 2024: $1,298 · 2025: $1,323.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,832 · Education: $43.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,831.88 |
| Education | $43.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,189.95 | 2019-2025 | Skyrizi, Rinvoq, Linzess |
| Takeda Pharmaceuticals U.S.A., INC. | $1,057.81 | 2019-2025 | Entyvio, Eohilia, Gattex |
| Janssen Biotech, INC. | $589.48 | 2019-2025 | Stelara, Tremfya, Simponi |
| Gilead Sciences, INC. | $533.81 | 2019-2025 | |
| Genzyme Corporation | $344.06 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $327.50 | 2022-2025 | Dupixent |
| Pfizer INC. | $316.92 | 2019-2025 | |
| Celgene Corporation | $209.80 | 2022-2024 | Zeposia |
| Lilly USA, LLC | $158.21 | 2024-2025 | Omvoh |
| Merck Sharp & Dohme LLC | $115.50 | 2019-2020 | |
| Intercept Pharmaceuticals, INC. | $112.52 | 2019-2025 | Ocaliva |
| Janssen Scientific Affairs, LLC | $103.10 | 2020 | |
| Organon LLC | $102.85 | 2022-2025 | Renflexis, Hadlima, Nexplanon |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $100.94 | 2019-2024 | Xifaxan |
| Medtronic, INC. | $97.30 | 2021-2023 | Gi Genius |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $97.02 | 2019-2023 | Injectafer |
| Celltrion USA INC. | $74.56 | 2025 | Vegzelma |
| Phathom Pharmaceuticals, INC. | $74.22 | 2024 | Voquezna |
| Shionogi INC | $64.75 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $61.70 | 2021-2022 | |
| Aimmune Therapeutics, INC. | $61.13 | 2024-2025 | Zenpep |
| Endo Pharmaceuticals INC. | $52.80 | 2019 | |
| Olympus America INC. | $49.39 | 2019-2020 | |
| Ethicon US, LLC | $45.57 | 2019-2020 | |
| Blueprint Medicines Corporation | $44.56 | 2023 | |
| Ferring Pharmaceuticals INC. | $43.19 | 2021-2023 | Rebyota |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.19 | 2023 | Cyltezo |
| Ardelyx, INC. | $40.00 | 2022-2024 | Ibsrela |
| Ironwood Pharmaceuticals, INC | $34.77 | 2019-2022 | |
| Echosens North America, INC. | $28.17 | 2024 | Fibroscan |
| Fujifilm Healthcare Americas Corporation | $24.84 | 2024 | Fujifilm |
| Shire North American Group INC | $24.11 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $21.99 | 2025 | Iqirvo |
| Madrigal Pharmaceuticals | $20.83 | 2025 | Rezdiffra |
| Novo Nordisk INC | $20.81 | 2025 | Wegovy |
| Qol Medical, LLC | $19.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Caufield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.